DUBLIN--(BUSINESS WIRE)--The "Global Nucleic Acid Labeling Market - Segmented by Label Type (Biotin-based, Fluorescent, Radioactive, and Others), by Technique, by Application, and by Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The Nucleic Acid Labeling market is expected to register a CAGR of 9% over the forecast period
Nucleic acids are complex biomolecules that are responsible for the transfer of genetic information in all living organisms. Nucleic acid labeling is a procedure in which nucleic acids are modified or attached with tags that enable their detection or purification. Common labels used to generate nucleic acid probes include biotin, radioactive phosphates, fluorophores, and enzymes.
Factors such as rising genomic and enzymology research, advancements in tools for synthetic genome design, and the growing trend of personalized medicine are contributing to the growth of the market. However, high cost, complexity of techniques, and the lack of skilled professionals could adversely affect the market growth.
Personalized medicine aims to provide tailor-made therapies to individual patients, depending on the molecular basis of disease, has become popular over the recent years. The aging global population and the rising prevalence of chronic disease are factors that are putting unrelenting pressure on the capacity and financial viability of healthcare systems, across the world.
Personalized medicine holds the promise of providing better patient care and a high safety margin, while also lowering total healthcare costs. Rising demand for personalized medicine has created tremendous opportunities in the field of genetic medicine, and in order to exploit these opportunities, novel technologies are to be developed, which, in turn, has resulted in the rapid expansion of the nucleic acid labeling market.
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Market Dynamics
7. Market Segmentation
8. Key Players and Competitive Landscape
9. Future of the Market
Companies Mentioned
- Enzo Biochem Inc.
- GE Healthcare
- Marker Gene Technologies Inc.
- Merck KGaA
- New England Biolabs Inc.
- PerkinElmer Inc.
- Promega Corporation
- Thermo Fisher Scientific Inc.
- Vector Laboratories Inc.
For more information about this report visit https://www.researchandmarkets.com/research/t3s9zb/global_nucleic?w=4
